PUBLISHER: Allied Market Research | PRODUCT CODE: 1193232
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193232
Speech therapy is used to diagnose and treat the speech and communication issues. It is carried out by speech-language pathologists (SLPs), sometimes known as speech therapists. It improves the communication by giving various therapies such as articulation therapy, language intervention activities, and others depending on the type of speech or language disorder. The symptom of speech disorders include repeating sounds, blinking several times while talking, adding extra sounds and words.
The growth of global speech therapy market is majorly driven by increase in demand for speech therapy, owing to increase in prevalence of neurological conditions and speech disorder. In addition, increase in awareness regarding speech therapy in developed countries such as the U.S. and rise in adoption of speech therapy due to advanced technologists such as teletherapy further fuel the market growth. However, high cost associated with speech therapy may hinder the market growth. Conversely, increase in neurological conditions such as Alzheimer disease, Parkinson's disease and others which causes speech related problems are anticipated to provide lucrative opportunities to the market players.
The global speech therapy market is segmented into type, age, end user and region. On the basis of type, the market is categorized into speech disorder, neurological condition, and others. By age, it is classified into pediatrics and adults. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits For Stakeholders
By Type
By Age
By End User
By Region